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Eustachian tube balloon dilations 1491. Introduction
There is no unanimous consensus for indications of eusta-
chian tube balloon dilation (ETBD). Nordic countries have
relatively similar hospital organizations and treatment
guidelines. Therefore, it was logical to organize a consensus
meeting of ETBD. The initiative for a Nordic consensus
symposium for ETBD came from professor Therese Ovesen,
Aarhus University, Denmark. A working group of her and
Juha Silvola from Norway started to prepare the sympo-
sium. The meeting had as goal to define Nordic consensus of
diagnosis, indications, treatment and outcomes of ETBD.
2. Material and methods
On the day before the symposium, professor Holger Sudhoff
(Bielefeld, Germany) hold an outstanding presentation of
the past, present and future of ETBD. During the sympo-
sium: Nordic Experiences on Eustachian Tube Balloon Dila-
tion, in Copenhagen, 30e31 March, 2017, the panellists
(Juha Silvola, Norway; Saku Sinkkonen, Finland; Jens
Wanscher, Denmark; Eva Westman, Sweden) and the at-
tendees of the meeting agreed upon the following for the
consensus: Candidates, Definition of Eustachian Tube
Dysfunction, Diagnostic work up, Differential diagnosis,
Contraindications, ETBD procedure, Complications, Follow-
up, and Outcomes.
Each panellist gave his or her own presentation of these
themes. Thereafter the consensus meeting made in plenum
a Nordic recommendation for each issue. This article also
presents the status for ETBD in each of these countries.
Objective: Establish a Nordic consensus evaluating the
diagnosis, indications, treatment and outcomes of ETBD.
3. Results
3.1. Nordic consensus on Eustachian Tube Balloon
Dilation (ETBD)
Candidates: adults (18 years), only selected pediatric
cases are offered ETBD.
Definition of Eustachian Tube Dysfunction (ETD):
There are three types of ETD, obstructive, acutebaro-
induced and tuba aperta, according to: Schilder et al.
“Eustachian tube dysfunction: consensus statement on
definition, types, clinical presentation and diagnosis”.1
Diagnostic work up: thorough endoscopy of the nasal
cavity and pharynx, otomicroscopy, Valsalva, Toynbee,
tympanometry, and audiometry. CT by indication. Tympa-
nostomy tube treatment is recommended before ETBD. The
diagnosis of ETD should be doubted if the patient does not
gain any benefit of tympanostomy tube treatment. More
studies are warranted on tubomanometry and the 7 item
questionnaire ETDQ7.
Differential diagnosis: patent ET (presence of respira-
tory autophony, movements of the tympanic membrane
during reflex decay measurement, and absence of
conductive hearing loss) and anatomical variations of the
inner ear (third window, like Minor’s Syndrome) that mim-
ick patent ET.Contraindications: patent ET, malformations of the
temporal bone and carotid artery.
ETBD procedure: general anaesthesia (local anaesthesia
may be used in selected cases). If indicated, the procedure
is performed on both ears. Other middle ear surgery may be
performed in the same anaesthesia, e.g., tympanostomy,
myringotomy, removal of cholesteatoma.
Complications: rare; emphysema due to balloon rupture
or tear of the mucosae followed by too early Valsalva
manoeuvre, patent ET (probably due to wrong diagnosis
before ETBD).
Follow-up: 3, 6, and 12 months (at least) with otomi-
croscopy, Valsalva, tympanometry, and audiometry. Patient
reported outcome.
Outcome: 70%-80% experiences various degrees of
improvement according to the literature.
3.2. ETBD status in Denmark
In 2012, ETBD was introduced as a treatment of ETD in
Denmark. Since then, 1119 procedures have been per-
formed (Fig. 1). So far, ETBD is performed at seven centers
across Denmark: Rigshospitalet (Copenhagen), Nordsjæl-
lands Hospital, Zealand University Hospital, Odense Uni-
versity Hospital/OUH Svendborg Sygehus, Hospital of South
West Jutland, Aalborg University Hospital and Regional
Hospital West Jutland.
In January 2019, a national consensus paper was pub-
lished in the Danish Medical Journal.2 The author-list con-
sists of one author of each center performing ETBD. We aim
to create a national database where all patients, who un-
dergoes first time ETBD in Denmark, are registered. This
will facilitate further research and possibly help assessing
which factors increase the likeliness of effect from ETBD.
This will make it possible to offer ETBD to patients who are
expected to benefit from the treatment.
3.3. ETBD status in Finland
In 2009, ETBD was introduced as a treatment of ETD in
Finland. Since then, 1452 procedures have been performed
(Fig. 2), about 300 operations yearly per 5.5 million in-
habitants. ETBD is performed by otolaryngologists at all the
levels of health care: at the five university hospitals, at
central hospitals around the county, and also at private
institutions.
In the 2016 annual meeting of the Finnish Otosurgical
Society there was a workshop on ETBD. The workshop
included a review of the eustachian tube physiology, middle
ear aeration mechanisms, and ETBD outcome studies.
Thereafter, the members of the society first voted and then
discussed 14 patient cases in order to conclude whether
ETBD was indicated in each case. Subsequently, a
consensus statement on the possible indications for ETBD
was outlined. The proposed indications for ETBD by the
Finnish Otosurgical Society in 2016 included (1) chronic
bothersome symptoms referring to ETD, (2) baro-induced
ETD, and (3) recurring serous otitis media.3 With the
available evidence, it was suggested to treat only adults
with ETBD. It was stressed that the patient selection was of
crucial importance. Diagnosis of the dysfunction should be
Fig. 1 Number of ETBDs per year in Denmark.
150 J.T. Silvola et al.done according to the consensus statement.1 Chronic
sinusitis, nasal polyposis, allergies, reflux disease and
enlarged adenoid should always be treated beforehand. It
is recommended to stop smoking. Before the operation
there should always be prior test and benefit with the
tympanostomy tubes, excluding the cases of baro-induced
ETD.
3.4. ETBD status in Norway
ETBD was introduced in Norway in 2012. Two national
courses have been arranged since then and the interest for
ETBD is increasing.Fig. 2 Number of patients treated with ETBD per year in
Finland (Source: National Institute for Health and Welfare).The total number of ETBD in Norway is difficult to
collect, as the sales agents have changed and are not
available anymore. The sale of Acclarent Aera balloon
ceased in 2015 because of the lack of CE certificate.
Thereafter all hospitals have gradually turned to use the
Spiggle&Theis 3.2  20 mm balloon until 2017 when also the
Entellus balloon came to markets. The numbers for Spig-
gle&Theis balloon sold since 2015 are shown in Fig. 3. The
main use is in the South-East Health District, with 2 large
university hospitals. About 10% of the procedures are per-
formed in private hospitals and clinics.
All but one of the five university hospitals use ETBD, and
the last university hospital has also signaled interest to
start with ETBD.
One of the problems with increased use of ETBD is the
reimbursement system in Norway, that makes ETBD pro-
cedure economically little attractive.Fig. 3 Number of numbers for Spiggle&Theis balloon sold in
Norway per year.
Fig. 4 Estimated number of patients operated with ETBD,
either bi- or unilateral procedures, per year in Sweden from
February 2014 to December 2018.
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equal, about 5 million, and it seems that the use of balloons
has stabilized now to the level of 300 balloon dilations a
year in Denmark and Finland. This is one ETBD procedure
per 18 000 inhabitants. The figures in Norway are a little bit
lower compared with other Nordic countries with equal
population. There is a clear increasing interest to ETBD and
it can be assumed that the use will rise to the same level of
Denmark and Finland.
In Norway the need for clinical hands-on courses for
ETBD is obvious. There are now several plans and ongoing
clinical studies for ETBD in different indications, alders and
combination with ear surgery.
3.5. ETBD status in Sweden
In 2014 ETBD was introduced in Sweden, primarily in one
county. Gradually other clinics started and in 2017 there
were 8 ENT clinics performing ETBD. After an inquiry it is
estimated that approximately 250 patients have been
operated since 2014, either bi- or unilateral (Fig. 4). A
majority of these were adults and only a few children. The
clinics in the county where ETBD was introduced were
responsible for approximately 25% of the procedures in
2018 and half of the total number of patients. The clinicians
have generally been cautious with this new treatment op-
tion for ETD and several of the university hospitals are not
performing this procedure yet. No national consensus has
been drafted so far but the Nordic consensus has generally
been followed. A few studies have been undertaken, no one
published so far, of which one was a RCT comparing two
intervention groups with a control group performing Val-
salva maneuver. A version of EDTQ-7 in Swedish is used by
several clinics but the questionnaire is not validated yet.
The number of patients operated annually have decreasedsince 2015 but might increase in the future. This will
probably depend on whether more of the ENT clinics,
including University hospitals and the private clinics, will
start with ETBD as a treatment option. A general comment
is that more data, including results from long-term follow-
up, are needed.
4. Discussion
The use of ETBD seems to have reached a steady state in
Denmark and Finland. This is probably not indicative for the
true amount of patients who can benefit from this pro-
cedure, but delay with new methods and instruments.
Nordic countries have relatively similar public hospital
service and the otolaryngologists in Nordic countries follow
the development in neighboring countries. It can be
anticipated that the use of ETBD in Sweden and Norway will
gradually increase to the same level as in Denmark and
Finland. Further research and evidence of the benefits of
ETBD will be needed. It can be assumed that surgeons in the
hospitals of Nordic countries generally follow the recom-
mendations of the consensus meeting.
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